Early Feasibility Study of 3930M Defibrillation Lead Implantation Via the Middle Cardiac Vein in Patients With Tricuspid Valve Regurgitation

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
Prospective, single center, early feasibility study designed to evaluate the initial safety and device performance of the Medtronic 3930M Lead when implanted via the Middle Cardiac Vein in patients with Tricuspid Valve Regurgitation
Epistemonikos ID: c21559272cf5e208d7f139014de02594700f6b2c
First added on: Sep 11, 2026